SORRENTO THERAPEUTICS, INC. Common Stock (par value $0.0001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • November 4th, 2014 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledNovember 4th, 2014 Company Industry JurisdictionSorrento Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows: